Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
January 24, 2023 08:30 ET
|
Nexalin Technology, Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of Michael Nketiah as Senior Vice President of...
Nexalin Technology CEO Provides Letter to Shareholders
January 05, 2023 08:30 ET
|
Nexalin Technology, Inc.
HOUSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today provided the following business update and letter to shareholders from...
Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder
November 14, 2022 14:00 ET
|
Nexalin Technology, Inc.
The Second Xiangya Hospital of Central South University, China, reports positive patient results, including disappearance of all somatic anxiety symptoms and improved quality of sleep Treatment...
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering
September 20, 2022 13:12 ET
|
Nexalin Technology, Inc.
HOUSTON, TEXAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the closing of its previously announced initial public offering of 2,315,000...
Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial Public Offering
September 15, 2022 20:54 ET
|
Nexalin Technology, Inc.
HOUSTON, TEXAS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the pricing of its initial public offering of 2,315,000 units consisting of...